about
The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions.Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.Pregnancy and Labor Complications in Female Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study.Employment status and occupational level of adult survivors of childhood cancer in Great Britain: The British childhood cancer survivor study.Physical activity and risk of prostate and bladder cancer in China: The South and East China case-control study on prostate and bladder cancerMortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.A meta-analysis on the association between bladder cancer and occupation.Long-term adverse outcomes in survivors of childhood bone sarcoma: the British Childhood Cancer Survivor Study.Aspects of mental health dysfunction among survivors of childhood cancer.Offspring sex ratio and gonadal irradiation in the British Childhood Cancer Survivor StudyPopulation-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study.International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics.Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study.Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study.ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres.Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study.Risk of Adverse Health and Social Outcomes Up to 50 Years After Wilms Tumor: The British Childhood Cancer Survivor Study.The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study.Extent of alcohol consumption among adult survivors of childhood cancer: the British Childhood Cancer Survivor Study.ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.Dietary consumption and diet diversity and risk of developing bladder cancer: results from the South and East China case-control study.Educational attainment among adult survivors of childhood cancer in Great Britain: a population-based cohort study.Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk.Health care use of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study.Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.Risk of bladder tumours after childhood cancer: the British Childhood Cancer Survivor Study.Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe.Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.Long-term population-based risks of breast cancer after childhood cancer.Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study.The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries.The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.Respiratory mortality of childhood, adolescent and young adult cancer survivors.The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information
P50
Q31064729-5C671FEA-853E-4ABF-83FA-8FB7B3A098B1Q33613662-F71B6ADF-9E5C-452D-ADFB-3302A303B7EBQ33614446-645DC0D4-A721-4F35-A7F0-191238DAAF31Q33698145-1D9E14F4-9B68-414A-8E29-EB846D745CA0Q33757541-16157510-A9B3-4287-A38B-08B674DB7D0BQ34025164-40E869B1-3723-4A45-B48B-122EF2282B5CQ34836590-9B10CABE-048B-46A6-AE17-E5CA8FE7C8E6Q36086856-0085112A-3159-4C5A-A1A1-5E37C1DB81F8Q36295029-714BA1F9-824A-44FC-AFEC-64EF548E43DDQ36610351-027AF652-EE33-42FE-8895-3AEB1C04E922Q36734173-5DD7E4F7-A3F3-476B-8429-220AA94E92AEQ37067875-4882BD80-D7A6-408F-BB23-32678A18EAA7Q37226566-83799B3F-7CBB-4C88-AFDE-B0144A8608D3Q37314918-C510BEDD-7C11-41C2-833D-FEB1A11603EFQ37371118-712923E6-AB35-4C43-859F-FF9D9C7762E7Q37409640-269495E6-137C-4252-817D-84D39462A3C6Q37682745-9705FDE2-74B6-48B0-AA77-4DB124914174Q38999011-B1B740BB-E25C-490F-93F2-8B562EE57FB2Q39707930-2FE2D51E-74FF-470A-8756-8DE28754CA6AQ40829568-293F6112-4A25-4BB9-AB8A-C5DFA0D1C256Q41004401-A313BABB-97CC-4411-8E96-E5C605FAC001Q43071590-A3DB425A-3050-464A-856D-90FFC39B3718Q43266183-DB8E4382-3735-47D8-9F75-9FD57A763645Q43786340-972ADF27-EF70-474A-B138-CFDE5F92E8BAQ44254883-F4052BBC-9A61-49C6-B188-48568AA030A9Q44590153-19B80D8D-B8F2-4CD3-B419-B51F8238FD8EQ44771956-0001EEEE-3238-4A6C-9107-F6BCE69DD258Q45905491-65E6FD87-20B3-42CB-BC5F-A92C2F733615Q46141303-2127CB44-05D8-4040-82EE-63C243CABD5BQ46247704-DC172490-280E-408E-A496-5F5D8EE9BB3AQ47100396-268CDC55-619A-4C5B-92A3-4C644BADED03Q47428806-F7D8FC98-0D0B-4E39-9B79-ACC1362F5906Q47676704-045EC567-812F-4C40-B2B1-C84EFA113245Q48447751-FEFAB112-468B-4B6E-9C45-5135805F3064Q51687967-D210E933-AC90-4A2B-99A9-F08761BDD125Q52581511-31E42493-474A-454E-9464-5DBA4A43C28AQ55256588-4C39560F-332D-4F2B-9CF4-4A3DA5855EF4Q55465612-C4DCF4A8-3AED-4DBB-832F-E89AD5B39C21Q65001990-D319A80F-2D09-4430-BBF7-9E65C0D36B68Q81236514-6F053B2E-F697-4FD0-B229-CB79B735CF49
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Raoul C Reulen
@ast
Raoul C Reulen
@en
Raoul C Reulen
@es
Raoul C Reulen
@nl
Raoul C Reulen
@sl
type
label
Raoul C Reulen
@ast
Raoul C Reulen
@en
Raoul C Reulen
@es
Raoul C Reulen
@nl
Raoul C Reulen
@sl
altLabel
Raoul Reulen
@en
Reulen R
@en
prefLabel
Raoul C Reulen
@ast
Raoul C Reulen
@en
Raoul C Reulen
@es
Raoul C Reulen
@nl
Raoul C Reulen
@sl
P106
P21
P31
P496
0000-0002-7328-0467